We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Stunted Microbiota and Opportunistic Pathogen Colonize C-Section Birth

By LabMedica International staff writers
Posted on 10 Oct 2019
Immediately after birth, newborn babies experience rapid colonization by microorganisms from their mothers and the surrounding environment. More...
Infants born by caesarean section have gut microbiomes that differ from those of infants born vaginally, carrying more hospital-associated opportunistic pathogens.

Diseases in childhood and later in life are potentially mediated by the perturbation of the colonization of the infant gut microbiota. However, the effects of delivery via caesarean section on the earliest stages of the acquisition and development of the gut microbiota, during the neonatal period (≤1 month), remain controversial.

Scientists from the Wellcome Sanger Institute (Hinxton, UK) and their colleagues collected fecal samples from 596 healthy babies through the Baby Biome Study. All infants were sampled at least once during their first month of life and 302 were sampled again when they were a few months old. Of these babies, 314 were born vaginally and 282 by C-section. DNA was extracted from 30 mg of fecal samples and DNA samples, including negative controls, were quantified by PicoGreen dsDNA assay.

The team found that babies born vaginally had gut microbiomes enriched with commensal bacteria like Bifidobacterium, Escherichia, Bacteroides, and Parabacteroides. Babies born by caesarean section had gut microbiomes that were depleted of those commensal bacteria, but instead harbored hospital-associated bacteria like Enterococcus faecalis, Staphylococcus epidermis, Klebsiella pneumoniae, and Clostridium perfringens. They also profiled the gut microbiomes of 178 mother-baby pairs to find that Bacteroides, Parabacteroides, Bifidobacterium, and E. coli were most frequently transmitted from mother to baby during vaginal birth. They also noted that these bacteria did not originate from the mother's vaginal microbiome, but from her gut microbiome.

Nigel Field, PhD, an infectious disease epidemiologist and academic public health consultant and a senior author of the study, said, “After they have been weaned, the microbiome differences between babies born via caesarean and delivered vaginally have mainly evened out. We don't yet know whether the initial differences we found will have any health implications. The study was published on September 18, 2019, in the journal Nature.

Related Links:
Wellcome Sanger Institute


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.